1. Home
  2. IVDA vs PMCB Comparison

IVDA vs PMCB Comparison

Compare IVDA & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

N/A

Current Price

$0.21

Market Cap

3.7M

Sector

Technology

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$128.63

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IVDA
PMCB
Founded
2003
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
4.0M
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
IVDA
PMCB
Price
$0.21
$128.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
127.7K
★ 167.6K
Earning Date
11-24-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.38
N/A
EPS
★ N/A
N/A
Revenue
★ $4,468,279.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 132.98
N/A
52 Week Low
$0.18
$0.25
52 Week High
$1.52
$1.51

Technical Indicators

Market Signals
Indicator
IVDA
PMCB
Relative Strength Index (RSI) 41.84 98.99
Support Level $0.18 $0.60
Resistance Level $0.34 N/A
Average True Range (ATR) 0.02 0.17
MACD 0.00 0.42
Stochastic Oscillator 47.46 82.66

Price Performance

Historical Comparison
IVDA
PMCB

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: